MedPath

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Phase 2
Terminated
Conditions
Hormone-Refractory Prostate Cancer
Prostatic Neoplasms
Registration Number
NCT00048659
Lead Sponsor
Astellas Pharma Inc
Brief Summary

The purpose of this study is to determine if patients who take YM598 in addition to mitoxantrone and prednisone (standard therapy) experience improvement in the pain associated with prostate cancer metastases in the bone.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (53)

Michiana Hematology/Oncology

๐Ÿ‡บ๐Ÿ‡ธ

South Bend, Indiana, United States

Centre Paul Papin

๐Ÿ‡ซ๐Ÿ‡ท

Angers, France

Dept Urology University of Essen

๐Ÿ‡ฉ๐Ÿ‡ช

Essen, Germany

Queen Elizabeth Hospital, Clinical Hematology & Oncology

๐Ÿ‡ฆ๐Ÿ‡บ

Woodville, Australia

Centre Hospitalier Notre Dame et Reine Fabiola, Service d'oncologie

๐Ÿ‡ง๐Ÿ‡ช

Charleroi, Belgium

Sylvester Comprehensive Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

University of Illinois, Department of Urology

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Universitair Medisch Centrum Utrecht, Dienst Medische Oncologie

๐Ÿ‡ณ๐Ÿ‡ฑ

Utrecht, Netherlands

Alaska Clinical Research Center, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Anchorage, Alaska, United States

Western Clinical Research, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Torrance, California, United States

San Bernardino Urological Associates

๐Ÿ‡บ๐Ÿ‡ธ

San Bernardino, California, United States

Shands Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Gainesville, Florida, United States

Georgia Urology,PA Research Institute

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

University of Chicago, Section of Hematology/Oncology

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Henry Ford Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Detroit, Michigan, United States

The Urologic Institute of New Orleans

๐Ÿ‡บ๐Ÿ‡ธ

Gretna, Louisiana, United States

Memphis Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Memphis, Tennessee, United States

Washington University School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

St. Louis, Missouri, United States

Virginia Mason Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Seattle, Washington, United States

Department of Medical Oncology, The Canberra Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Canberra, Australia

Division of Oncology Ward, Royal Brisbane Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Herston, Australia

Department of Medical Oncology, Concord Hospital Medical Centre

๐Ÿ‡ฆ๐Ÿ‡บ

Concord, Australia

Southern Medical Day Care Centre

๐Ÿ‡ฆ๐Ÿ‡บ

Wollongong, Australia

Cliniques Universitaires St-Luc, Service d'Urologie

๐Ÿ‡ง๐Ÿ‡ช

Bruxelles, Belgium

Department of Clinical Oncology, Royal North Shore Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

St Leonards, Australia

Cancer Care Centre, St. George Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, Australia

Service d'Urologie, Hรดpital Henri Mondor

๐Ÿ‡ซ๐Ÿ‡ท

Creteil, France

Service d' Urologie CHU, Hopital Bichat

๐Ÿ‡ซ๐Ÿ‡ท

Paris, France

Krankenhause am Urban, Urologie Dieffenfachstr

๐Ÿ‡ฉ๐Ÿ‡ช

Berlin, Germany

Mater Misericordiae Hospital

๐Ÿ‡ฎ๐Ÿ‡ช

Dublin, Ireland

Kilinika Chemioterapii, Centrum Onkologii Instytut im M sklodowskiej Curie

๐Ÿ‡ต๐Ÿ‡ฑ

Krakow, Poland

Klinikum Mannheim Urology

๐Ÿ‡ฉ๐Ÿ‡ช

Mannheim, Germany

Hospital Universitario de Getafe, Servicio de Urologia, Crta

๐Ÿ‡ช๐Ÿ‡ธ

Getafe (Madrid), Spain

Hospital Clinic i Provincial, Servicio de Oncologia

๐Ÿ‡ช๐Ÿ‡ธ

Barcelona, Spain

Oddzial Chemioterapii

๐Ÿ‡ต๐Ÿ‡ฑ

Krakow, Poland

Szpital Wojewodzki im Sw Lukasza SP ZOZ Tarnow

๐Ÿ‡ต๐Ÿ‡ฑ

Tarnow, Poland

Klinika Chemioterapii AM

๐Ÿ‡ต๐Ÿ‡ฑ

Lodz, Poland

Samodzielny Publiczny Zaklad Opieki zdrowotnej, Wojewodzki Osrodek Onkologii

๐Ÿ‡ต๐Ÿ‡ฑ

Opole, Poland

Department of Urological Research, Derriford Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Devon, United Kingdom

Instituto Valenciano de Oncologia, Servicio de Oncologia

๐Ÿ‡ช๐Ÿ‡ธ

Valencia, Spain

Clinical Research Centre, St George's Hospital, Urology Division

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Imperial College School of Medicine, Dept Cancer Medicine

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Department of Urology, St Bartholomew's Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Department of Urology, East Surrey Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Surrey, United Kingdom

St Richard's Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

West Sussex, United Kingdom

Royal Surrey County Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Surrey, United Kingdom

Department of Medical Oncology, Newcastle Mater Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Waratah, Australia

Pavillon V, Service d'Urologie et de transplatation, Hรดpital Edouard Herriot

๐Ÿ‡ซ๐Ÿ‡ท

Lyon, France

Hospital Universitario Prรญncipe de Asturias, Servicio de Urologรญa

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

Urologische Klinik der MHH

๐Ÿ‡ฉ๐Ÿ‡ช

Hannover, Germany

Hospital General Vall d'Hebron, Servicio de Oncologรญa

๐Ÿ‡ช๐Ÿ‡ธ

Barcelona, Spain

Klinika Nowotworow Ukladu

๐Ÿ‡ต๐Ÿ‡ฑ

Warszawa, Poland

Szpital CSK WAMl, Klinika Okologii

๐Ÿ‡ต๐Ÿ‡ฑ

Warsaw, Poland

ยฉ Copyright 2025. All Rights Reserved by MedPath